MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of securities
$25,805K
Proceeds from exercise of
stock options
$1,105K
Net cash provided by
investing activities
$14,233K
Net cash provided by
financing activities
$1,105K
Canceled cashflow
$11,572K
Net increase in
cash, cash...
$2,238K
Canceled cashflow
$13,100K
Purchases of securities
$11,062K
Purchases of property and
equipment
$510K
Stock-based compensation
$1,362K
something is missing
$1,348K
Amortization of operating
lease right-of-use...
$1,142K
Accounts payable
$200K
Accrued expenses and
other liabilities
$128K
Net cash used in
operating activities
-$13,100K
Canceled cashflow
$4,180K
Net loss
-$14,697K
Operating lease
liabilities
-$1,146K
Depreciation
-$1,014K
Prepaid expenses and
other assets
$355K
Amortization (accretion) of
premiums (discounts) on...
$68K
Back
Back
Cash Flow
source: myfinsight.com
Nautilus Biotechnology, Inc. (NAUT)
Nautilus Biotechnology, Inc. (NAUT)